q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

August 2017 summary of the new medications added to Medicare Part D prescription drug plan formularies (drug lists)

Category: Monthly Formulary Changes
Published: Sep, 02 2017 09:09:43
< Previous
Next >
The August, 2017 Medicare Part D plan formulary data (or drug list updates) includes the addition of 102 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 63 different drugs, many with multiple strengths.

Seven (7) new generic equivalents were added, Clofarabine, the generic for Clolar(r), Busulfan, the generic for Busulfex(r), multiple strengths of Ezetimibe-Simvastatin, the generic for Vytorin (r), multiple strengths of FLUTICASONE-SALMETEROL, the generic for Advair Diskus(r), Advair HFA(r), and AIRDUO RESPICLICK(r), Meperidine Hydrochloride, the generic for Demerol(r), Tazarotene, the generic for Tazorac(r), and Zileuton the generic for Zyflo(r).

What exactly is an NDC?
As a reminder, the NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC for your medication is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

Why is there a new NDC?
New NDCs can be added to the Medicare Part D program for a number of reasons and a summary for all 43 new medications is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 2
New Delivery Form and Strength 1
New Drug 26
New Drug and Delivery Form 2
New Drug and Strength 37
New Drug, Delivery Form and Strength 1
New Manufacturer 3
New Manufacturer and Delivery Form 3
New Manufacturer and Strength 9
New Manufacturer, Strength and Delivery Form 2
New Strength 15
New Strength and Packaging 1
Total New NDCs 102

More about the newly added NDCs ...
The following chart details the 103 new manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
59310081206AIRDUO RESPICLICK 113-14 MCGNew Drug and Strength
59310082206AIRDUO RESPICLICK 232-14 MCGNew Drug and Strength
59310080506AIRDUO RESPICLICK 55-14 MCGNew Drug and Strength
76189011318ALUNBRIG 30 MG TABLETNew Drug
68382022714AMIODARONE HCL 200 MG TABLETNew Manufacturer and Strength
68546017260AUSTEDO 12 MG TABLETNew Drug and Strength
68546017060AUSTEDO 6 MG TABLETNew Drug and Strength
68546017160AUSTEDO 9 MG TABLETNew Drug and Strength
50419053001AVELOX 400 MG TABLETNew Drug and Delivery Form
50419053701AVELOX IV 400 MG/250 MLNew Drug and Delivery Form
44087353501BAVENCIO 200 MG/10 ML VIALNew Drug
00023438505BETAGAN 0.5% EYE DROPSNew Drug
00517092001Busulfan 60 mg/10 ml vial [Busulfex]New Drug
54838054070CITALOPRAM HBR 10 MG/5 ML SOLNNew Manufacturer and Delivery Form
63323057270Clofarabine 20 mg/20 ml vial [Clolar]New Drug
00093083301CLONAZEPAM 1 MG TABLETNew Strength and Packaging
17478060430COSOPT PF EYE DROPSNew Strength
52276040001CYSTADANE 1 GRAM/1.7 ML POWDERNew Drug
55292010401DESOXYN 5 MG TABLETNew Drug
42858012201DILAUDID 2 MG TABLETNew Drug and Strength
42858023450DILAUDID 4 MG TABLETNew Drug and Strength
42858041616DILAUDID 5 MG/5 ML ORAL LIQUIDNew Drug, Delivery Form and Strength
42858033801DILAUDID 8 MG TABLETNew Drug and Strength
00024591401DUPIXENT 300 MG/2 ML SAFE SYRGNew Drug
50242012203ESBRIET 267 MG TABLETNew Manufacturer and Delivery Form
00002416507EVISTA 60 MG TABLETNew Drug
00115138508Ezetimibe-Simvastatin 10-10 MG [Vytorin]New Drug and Strength
00115138608Ezetimibe-Simvastatin 10-20 MG [Vytorin]New Drug and Strength
00115138708Ezetimibe-Simvastatin 10-40 MG [Vytorin]New Drug and Strength
00115138808Ezetimibe-Simvastatin 10-80 MG [Vytorin]New Drug and Strength
68180086011Fayosim tabletNew Drug
00093360882FLUTICASONE-SALMETEROL 113-14 [Advair Diskus, Advair HFA, AIRDUO RESPICLICK]New Drug and Strength
00093360982FLUTICASONE-SALMETEROL 232-14 [Advair Diskus, Advair HFA, AIRDUO RESPICLICK]New Drug and Strength
00093360782FLUTICASONE-SALMETEROL 55-14 [Advair Diskus, Advair HFA, AIRDUO RESPICLICK]New Drug and Strength
63304062510FUROSEMIDE 40 MG TABLETNew Strength
00378023201FUROSEMIDE 80 MG TABLETNew Manufacturer and Strength
64208823506GAMMAPLEX 10 GRAM/100 ML VIALNew Strength
64208823503GAMMAPLEX 20 GRAM/200 ML VIALNew Strength
64208823505GAMMAPLEX 5 GRAM/50 ML VIALNew Strength
43547039711Hydrochlorothiazide 25 mg tabNew Manufacturer and Strength
00168028802HYDROCORTISONE 2.5% LOTIONNew Delivery Form
42806016110Hydroxyzine hcl 50 mg tabletNew Manufacturer and Delivery Form
00310450012IMFINZI 120 MG/2.4 ML VIALNew Drug and Strength
00310461150IMFINZI 500 MG/10 ML VIALNew Drug and Strength
31722054210Indomethacin 25 mg capsuleNew Strength
70370104001INGREZZA 40 MG CAPSULENew Drug
00085113301INTRON A 25 MILLION UNIT/2.5MLNew Strength
71090000101KEVEYIS 50 MG TABLETNew Drug
00024590801KEVZARA 150 MG/1.14 ML SYRINGENew Drug and Strength
00024591001KEVZARA 200 MG/1.14 ML SYRINGENew Drug and Strength
58160081201KINRIX VIALNew Delivery Form
00078090961KISQALI FEMARA 200 MG CO-PACKNew Strength
00078091661KISQALI FEMARA 400 MG CO-PACKNew Strength
00078092361KISQALI FEMARA 600 MG CO-PACKNew Strength
00143955801Levoleucovorin 50 mg vial [Fusilev]New Manufacturer and Strength
59762453702MEDROXYPROGESTERONE 150 MG/MLNew Drug
58160095509MENVEO A-C-Y-W-135-DIP VIALNew Drug
42806005001Meperidine Hydrochloride 50 MG Oral Tablet [Demerol]New Drug
00378004710METOPROLOL TARTRATE 100 MG TABNew Manufacturer and Strength
65597030410MORPHABOND ER 100 MG TABLETNew Drug and Strength
65597030110MORPHABOND ER 15 MG TABLETNew Drug and Strength
65597030210MORPHABOND ER 30 MG TABLETNew Drug and Strength
65597030310MORPHABOND ER 60 MG TABLETNew Drug and Strength
42858079901MS CONTIN 100 MG TABLETNew Drug and Strength
42858051501MS CONTIN 15 MG TABLETNew Drug and Strength
42858090001MS CONTIN 200 MG TABLETNew Drug and Strength
42858063101MS CONTIN 30 MG TABLETNew Drug and Strength
42858076001MS CONTIN 60 MG TABLETNew Drug and Strength
52544005841Norethin-estrad-ferr 1-0.02(24)-75New Manufacturer and Strength
60846088401PRANDIN 2 MG TABLETNew Strength
10702000201PROMETHAZINE 12.5 MG TABLETNew Manufacturer, Strength and Delivery Form
00603158758PROMETHAZINE VC SYRUPNew Manufacturer, Strength and Delivery Form
58160096412RABAVERT RABIES VACCINE VIALNew Manufacturer
70510217101RADICAVA 30 MG/ 100 MLNew Drug
49884031191RISPERIDONE 0.5 MG ODTNew Manufacturer
00781531208RISPERIDONE 2 MG ODTNew Manufacturer
00093603182Rivelsa tabletNew Drug
69102010301Roweepra 1,000 mg tabletNew Strength
69102010201Roweepra 750 mg tabletNew Strength
00078069819RYDAPT 25 MG CAPSULENew Drug
00078081181SANDOSTATIN LAR DEPOT 10 MG KTNew Strength
16714060102SERTRALINE 20 MG/ML ORAL CONCNew Drug
51672137303Tazarotene 0.1% Cream [Tazorac]New Drug
70839015030TEKTURNA 150 MG TABLETNew Manufacturer and Strength
70839030030TEKTURNA 300 MG TABLETNew Manufacturer and Strength
70839032530TEKTURNA HCT 300-25 MG TABLETNew Manufacturer and Strength
47781050801TETRACYCLINE 250 MG CAPSULENew Drug and Strength
00591247501TETRACYCLINE 500 MG CAPSULENew Drug and Strength
00574220545TRETINOIN 0.05% CREAMNew Drug and Strength
00574220145TRETINOIN 0.1% CREAMNew Drug and Strength
00781506805TRIAMTERENE-HCTZ 37.5-25 MG TBNew Strength
54738055401Trihexyphenidyl 2 mg tabletNew Drug and Strength
54738055501Trihexyphenidyl 5 mg tabletNew Drug and Strength
70539000101TYMLOS 80 MCG DOSE PEN INJECTRNew Drug
62847000101VIBATIV 750 MG VIALNew Drug
27505011130XADAGO 100 MG TABLETNew Drug and Strength
27505011030XADAGO 50 MG TABLETNew Drug and Strength
52652200101XATMEP 2.5 MG/ML ORAL SOLUTIONNew Drug
00024580121XYZAL 2.5 MG/5 ML SOLUTIONNew Delivery Form and Strength
69656010390ZEJULA 100 MG CAPSULENew Drug
64980020612Zileuton er 600 mg tablet [Zyflo]New Drug
70347020830ZONTIVITY 2.08 MG TABLETNew Drug

Looking for a way to review any Medicare Part D plan formulary?
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.
*Please remember that a Medicare prescription drug plan can change their plan's formulary at any time throughout the year (adding or dropping drugs) and you can telephone your Medicare plan's Member Services department to learn about the most recent formulary changes - the toll-free number for Member Services is found on your Member ID card.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com


Have a Medication Not Covered by Your Plan?
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
» Compare prices at pharmacies near you.
Your drug discount card is available to you at no cost.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.